|Bid||287.60 x 100|
|Ask||287.76 x 400|
|Day's Range||285.03 - 296.80|
|52 Week Range||244.28 - 333.65|
|PE Ratio (TTM)||18.04|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In 2Q17, Biogen (BIIB) generated revenue of ~$3.1 billion, a 6% rise year-over-year (or YoY) and a 9% rise quarter-over-quarter.
Categories: Yahoo FinanceGet free summary analysis Biogen, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Biogen, Inc. – Amgen Inc. and Johnson & Johnson (AMGN-US and JNJ-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 2,727.90 million, Net Earnings ... Read more (Read more...)
After a solid second quarter, management lays out plans for future growth.